» Articles » PMID: 1906036

Characterization and Molecular Cloning of Polypyrimidine Tract-binding Protein: a Component of a Complex Necessary for Pre-mRNA Splicing

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 1991 Jul 1
PMID 1906036
Citations 164
Authors
Affiliations
Soon will be listed here.
Abstract

alpha-Tropomyosin exons 2 and 3 are spliced in a mutually exclusive manner. Exon 3 is included as the default exon in the mRNA of most cell types, whereas exon 2 is only included in the mRNA of smooth muscle cells. The primary determinant for the default selection of exon 3 is the branchpoint/polypyrimidine tract. This element upstream of exon 3 clearly and effectively outcompetes the corresponding element upstream of exon 2. To identify trans-acting factors that bind to this important cis element, we used UV cross-linking to identify a 57-kD protein whose binding characteristics directly correlate with 3'-splice-site selection in cis-competition splicing assays. This protein appears to be identical to polypyrimidine tract-binding protein. In this report we have used oligonucleotides derived from peptide sequences to isolate and sequence cDNA clones encoding this 57.2-kD protein. The primary sequence reveals a novel protein with significant homology to other RNA-binding proteins. Expression of the mRNA is detected in all tissues and cells examined, although its levels exhibit tissue-specific and developmental regulation. Using a biochemical complementation assay, we have found that this protein, along with a 100-kD protein, exists as part of a large complex that is required to rescue splicing from depleted nuclear extracts.

Citing Articles

The Repurposing of Cellular Proteins during Enterovirus A71 Infection.

Abedeera S, Davila-Calderon J, Haddad C, Henry B, King J, Penumutchu S Viruses. 2024; 16(1).

PMID: 38257775 PMC: 10821071. DOI: 10.3390/v16010075.


Established and Evolving Roles of the Multifunctional Non-POU Domain-Containing Octamer-Binding Protein (NonO) and Splicing Factor Proline- and Glutamine-Rich (SFPQ).

Yu D, Huang C, Tucker H J Dev Biol. 2024; 12(1).

PMID: 38248868 PMC: 10801543. DOI: 10.3390/jdb12010003.


Neuronal conversion from glia to replenish the lost neurons.

Liang S, Zhou J, Yu X, Lu S, Liu R Neural Regen Res. 2023; 19(7):1446-1453.

PMID: 38051886 PMC: 10883502. DOI: 10.4103/1673-5374.386400.


Reviewing PTBP1 Domain Modularity in the Pre-Genomic Era: A Foundation to Guide the Next Generation of Exploring PTBP1 Structure-Function Relationships.

Carico C, Placzek W Int J Mol Sci. 2023; 24(13).

PMID: 37446395 PMC: 10342978. DOI: 10.3390/ijms241311218.


Therapeutic Potential of PTBP1 Inhibition, If Any, Is Not Attributed to Glia-to-Neuron Conversion.

Wang L, Zhang C Annu Rev Neurosci. 2023; 46:1-15.

PMID: 36750409 PMC: 10404630. DOI: 10.1146/annurev-neuro-092822-083410.